can semaglutide cause ketoacidosis GLP-1 mimetics and diabetic ketoacidosis: possible interactions and clinical consequences | Naunyn-Schmiedeberg's Archives of Pharmacology SGLT2 Inhibitor-induced Euglycemic Diabetic Ketoacidosis

Some patients report improvement in reflux symptoms, while others experience temporary worsening, especially during dose escalation

There have been other failed trials with LAG-3 contenders from other companies as well, such as Immutep's eftilagimod alfa, dropped for first-line NSCLC in combination with Keytruda and chemo after a phase 3 readout earlier this year, as well as MSD's candidate favezelimab, which was abandoned in 2024 after failed trials in lung and colorectal cancers

Retatrutide , a triple agonist that activates GLP-1, GIP, and glucagon receptors simultaneously, is in advanced clinical trials

The NDC must match the product actually administered